Drugs, Inc

question 24

Short Answer

Drugs, Inc. recently received approval from the Food and Drug Administration for its new supplemental drug application for a 300- milligram tablet of an antiplatelet treatment. The company invested $170 million in the research and development fund for this drug application 7 years ago. What is the present worth of the investment now, if the company achieves a rate of return of 2% per year?

---

Definitions:

Scope of Practice Barriers

Restrictions and limitations placed on professionals that define what activities they can perform within their field.

Nurse Residency Programs

These are structured programs for newly graduated nurses providing them with training, mentorship, and practical experience to transition from student to practicing nurse.

Short-Term Education

Educational programs or courses designed to be completed in a brief period, often focused on specific skills or knowledge.

Redesign

The process of revising and improving upon a current design or process to enhance functionality, efficiency, or aesthetics.